相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。First use of the anti-VWF nanobody caplacizumab to treat iTTP in pregnancy
Lucas Kuehne et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Clinical Management of Thrombotic Antiphospholipid Syndrome
Nor Rafeah Tumian et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Systemic Lupus Erythematosus Management in Pregnancy
Kathryn H. Dao et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2022)
Rituximab administration during the second trimester of pregnancy for systemic lupus erythematosus: Case report and review of the literature on rheumatic disease
Matthew Colquhoun et al.
MODERN RHEUMATOLOGY CASE REPORTS (2022)
Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications
Shruti Chaturvedi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study
Fadi Fakhouri et al.
BLOOD (2021)
Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis
Anja Gaeckler et al.
BMC NEPHROLOGY (2021)
Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Jillian T. Henderson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Markers of complement activation in plasma during quiescent phases in catastrophic antiphospholipid syndrome patients
Amelia Ruffatti et al.
BLOOD (2021)
Redefining outcomes in immune TTP: an international working group consensus report
Adam Cuker et al.
BLOOD (2021)
Understanding the Pathophysiology of Thrombotic APS through Animal Models
Alex A. Gandhi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Acute Fatty Liver of Pregnancy
David B. Nelson et al.
OBSTETRICS AND GYNECOLOGY (2021)
Outcomes of a clinician-directed protocol for discontinuation of complement inhibition therapy in atypical hemolytic uremic syndrome
Shruti Chaturvedi et al.
BLOOD ADVANCES (2021)
Epidemiology of Antiphospholipid Syndrome in the General Population
Jesse Y. Dabit et al.
CURRENT RHEUMATOLOGY REPORTS (2021)
Real-world experience with caplacizumab in the management of acute TTP
Tina Dutt et al.
BLOOD (2021)
How to evaluate and treat the spectrum of TMA syndromes in pregnancy
Marie Scully
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2021)
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
Fadi Fakhouri et al.
JOURNAL OF NEPHROLOGY (2021)
PlGF (Placental Growth Factor) Testing in Clinical Practice Evidence From a Canadian Tertiary Maternity Referral Center
Kelsey McLaughlin et al.
HYPERTENSION (2021)
Differentiating Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome and Atypical Hemolytic Uremic Syndrome in the Postpartum Period
Richard M. Burwick et al.
HYPERTENSION (2021)
Expert Perspective: Management of Microvascular and Catastrophic Antiphospholipid Syndrome
Doruk Erkan
ARTHRITIS & RHEUMATOLOGY (2021)
Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS
Shruti Chaturvedi et al.
BLOOD (2020)
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment
Eric Rondeau et al.
KIDNEY INTERNATIONAL (2020)
Pregnancy-Associated Atypical Hemolytic Uremic Syndrome A Systematic Review
Megha Gupta et al.
OBSTETRICS AND GYNECOLOGY (2020)
The natural course of pregnancies in women with primary atypical haemolytic uraemic syndrome and asymptomatic relatives
Sjoerd A. M. E. G. Timmermans et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases
Lisa R. Sammaritano et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Time from suspected thrombotic thrombocytopenic purpura to initiation of plasma exchange and impact on survival: A 10-year provincial retrospective cohort study
Daniel Sawler et al.
THROMBOSIS RESEARCH (2020)
ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura
X. Long Zheng et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
ISTH guidelines for treatment of thrombotic thrombocytopenic purpura
X. Long Zheng et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura
X. Long Zheng et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group
Fadi Fakhouri et al.
BLOOD (2020)
HEMATOLOGIC COMPLICATIONS IN PREGNANCY How I treat thrombotic thrombocytopenic purpura in pregnancy
Barbara Ferrari et al.
BLOOD (2020)
Success and limitations of plasma treatment in pregnant women with congenital thrombotic thrombocytopenic purpura
Kazuya Sakai et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
16th International Congress on Antiphospholipid Antibodies Task Force report on catastrophic antiphospholipid syndrome
Ricard Cervera et al.
LUPUS (2020)
A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP
Paul Coppo et al.
BLOOD (2020)
Gestational Hypertension and Preeclampsia
Jimmy Espinoza et al.
OBSTETRICS AND GYNECOLOGY (2020)
Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic Microangiopathy
Natalja Haninger-Vacariu et al.
KIDNEY MEDICINE (2020)
Adverse outcomes in obstetric-atypical haemolytic uraemic syndrome: a case series analysis
Natalia L. Kozlovskaya et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2019)
Etiology and Outcomes of Thrombotic Microangiopathies
Guillaume Bayer et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
EULAR recommendations for the management of antiphospholipid syndrome in adults
Maria G. Tektonidou et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Placental passage of eculizumab and complement blockade in a newborn
Caroline Duineveld et al.
KIDNEY INTERNATIONAL (2019)
Placental growth factor testing for suspected pre-eclampsia: a cost-effectiveness analysis
K. E. Duhig et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2019)
Chronic Kidney Disease and Pregnancy
Dini Hui et al.
OBSTETRICS AND GYNECOLOGY (2019)
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
M. Scully et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Catastrophic antiphospholipid syndrome in pregnancy: a life-threatening condition
Mandy Collict et al.
BMJ CASE REPORTS (2019)
Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand
Lucy C. Fox et al.
INTERNAL MEDICINE JOURNAL (2018)
The impact of eculizumab on routine complement assays
Maria A. Willrich et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2018)
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome
K. Legault et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome
Ana Huerta et al.
KIDNEY INTERNATIONAL (2018)
Microangiopathic Hemolytic Anemia in Pregnancy
Lucy Neave et al.
TRANSFUSION MEDICINE REVIEWS (2018)
Eculizumab in a pregnant patient with laboratory onset of catastrophic antiphospholipid syndrome A case report
Patrizia Rovere-Querini et al.
MEDICINE (2018)
Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome
Martina Gaggl et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Placental growth factor and pre-eclampsia
K. Chau et al.
JOURNAL OF HUMAN HYPERTENSION (2017)
Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies
M. Scully et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study
Pavan K. Bendapudi et al.
LANCET HAEMATOLOGY (2017)
High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
Lucy A. McNamara et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)
Thrombocytopenia in pregnancy
Douglas B. Cines et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2017)
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura
Marie Scully et al.
BLOOD (2017)
Hemolytic Uremic Syndrome in Pregnancy and Postpartum
Alexandra Bruel et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre
Maximilien Grall et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Congenital thrombotic thrombocytopenic purpura related to a novel mutation in ADAMTS13 gene and management during pregnancy
Narendranath Epperla et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
The Alternative Pathway of Complement and the Evolving Clinical-Pathophysiological Spectrum of Atypical Hemolytic Uremic Syndrome
Bruce E. Berger
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2016)
How we manage thrombotic microangiopathies in pregnancy
Mari R. Thomas et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review
Naoyuki Miyasaka et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Atypical haemolytic uraemic syndrome and pregnancy: outcome with ongoing eculizumab
Aude Servais et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
Harald Zeisler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
Andreas Barratt-Due et al.
RHEUMATOLOGY (2016)
Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy
Eric Mariotte et al.
LANCET HAEMATOLOGY (2016)
Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality
Ruchika Goel et al.
BLOOD (2015)
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria
Richard J. Kelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Antiphospholipid Syndrome-Not a Noninflammatory Disease
Philip G. de Groot et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2015)
Platelet transfusion and catheter insertion for plasma exchange in patients with thrombotic thrombocytopenic purpura and a low platelet count
Etienne Riviere et al.
TRANSFUSION (2015)
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
R. Cervera et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Eculizumab Prevents Recurrent Antiphospholipid Antibody Syndrome and Enables Successful Renal Transplantation
B. E. Lonze et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura
Yang Jiang et al.
BLOOD (2014)
Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes
Marie Scully et al.
BLOOD (2014)
Comprehensive Genetic Analysis of Complement and Coagulation Genes in Atypical Hemolytic Uremic Syndrome
Fengxiao Bu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Recurrent thrombosis prevention with intravenous immunoglobulin and hydroxychloroquine during pregnancy in a patient with history of catastrophic antiphospholipid syndrome and pregnancy loss
Nataliya Mar et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2014)
Syndromes of Thrombotic Microangiopathy
James N. George et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
ADAMTS13 content in plasma-derived factor VIII/von Willebrand factor concentrates
Flora Peyvandi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Cost and resource implications with serum angiogenic factor estimation in the triage of pre-eclampsia
W. T. Schnettler et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2013)
ADAMTS13 deficiency in severe postpartum HELLP syndrome
Olivier Pourrat et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical Phenotype
Elena Bresin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome
C. M. Legendre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura
Filip Callewaert et al.
BLOOD (2012)
Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura
Marie Moatti-Cohen et al.
BLOOD (2012)
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency
James N. George et al.
JOURNAL OF CLINICAL APHERESIS (2012)
Pregnancy outcomes after maternal exposure to rituximab
Eliza F. Chakravarty et al.
BLOOD (2011)
Epidemiological Approach to Identifying Genetic Predispositions for Atypical Hemolytic Uremic Syndrome
Maren Sullivan et al.
ANNALS OF HUMAN GENETICS (2010)
Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype
Marina Noris et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations
Fadi Fakhouri et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience
Paul Coppo et al.
PLOS ONE (2010)
Thrombomodulin Mutations in Atypical Hemolytic-Uremic Syndrome
Mieke Delvaeye et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
MEDICAL PROGRESS Atypical Hemolytic-Uremic Syndrome
Marina Noris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation
Anne-Lie Stahl et al.
BLOOD (2008)
Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency
Mihaly Jozsi et al.
BLOOD (2008)
Imitators of severe preeclampsia
Baha M. Sibai
OBSTETRICS AND GYNECOLOGY (2007)
The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients
Jane E. Salmon et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
The use of intermediate purity factor VIII concentrate BPL 8Y as prophylaxis and treatment in congenital thrombotic thrombocytopenic purpura
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
Richard J. Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura
Marie Scully et al.
BLOOD COAGULATION & FIBRINOLYSIS (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome
MA Dragon-Durey et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women
A Sánchez-Luceros et al.
THROMBOSIS AND HAEMOSTASIS (2004)
Factor VIII and !von Willebrand factor changes during normal pregnancy and puerperium
A Sánchez-Luceros et al.
BLOOD COAGULATION & FIBRINOLYSIS (2003)
Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura
H Yarranton et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines
RA Asherson et al.
LUPUS (2003)
ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions
JF Dong et al.
BLOOD (2002)
Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex:: studies using optical tweezers
M Arya et al.
BLOOD (2002)
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor
PM Mannucci et al.
BLOOD (2001)
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
GG Levy et al.
NATURE (2001)
分享论文
